Article

NCPA Offers Congress Recommendations to Fight Prescription Drug Abuse

The National Community Pharmacists Association endorsed a range of solutions to the prescription drug abuse epidemic and asked lawmakers to revise an overly restrictive "lock-in pharmacy" proposal limiting Medicare beneficiary access.

PRESS RELEASE

Alexandria, Va.- The National Community Pharmacists Association (NCPA) endorsed a range of solutions to the prescription drug abuse epidemic and asked lawmakers to revise an overly restrictive "lock-in pharmacy" proposal limiting Medicare beneficiary access, in comments submitted to the Senate Finance Committee, which held a hearing today entitled, "Examining the Opioid Epidemic: Challenges and Opportunities."

"NCPA stands ready to work with other stakeholders to stem the growing tide of opioid abuse and overdose and strongly believes that there are a number of potential strategies that can be utilized such as increased access to naloxone and enhanced prescription drug monitoring programs to address the problem," NCPA said in its comments.

- To help reduce prescription drug abuse, NCPA supports expanded access to naloxone; enhanced prescription drug monitoring programs; increased prescriber education; and more appropriate use of Risk Evaluation and Mitigation Strategies (REMS).

- Medicare has recently achieved significant progress tackling prescription drug abuse, NCPA noted. Agency officials just announced a 26 percent decrease from 2011 to 2014 of Medicare Part D beneficiaries identified as potential opioid over utilizers. This represents a 39 percent decrease in the share of beneficiaries using opioids who are identified as potential opioid over utilizers.

- Proposed legislation (S. 1913) to establish a Medicare "lock-in pharmacy" system limiting patient access to physicians and community pharmacies "would need a number of key edits to ensure that it would be a coordinated and even-handed program," NCPA said in offering several suggestions. Specifically, Medicare officials should administer the effort, rather than prescription drug plan sponsors, which may have a vested financial interest in steering beneficiaries to a particular pharmacy. By contrast, in virtually all of the 46 state Medicaid "lock-in" programs, it is the patient who determines which prescriber and pharmacy to use.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit: viperagp | stock.adobe.com
Image credit:  kitsawet | stock.adobe.com
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com